IBDEI3BM ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1676,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^22^128
 ;;^UTILITY(U,$J,358.4,1677,0)
 ;;=FAMILY HX EYE DISORDERS^17^128
 ;;^UTILITY(U,$J,358.4,1678,0)
 ;;=BLIND REHAB SERVICE CODES^11^129
 ;;^UTILITY(U,$J,358.4,1679,0)
 ;;=REFRACT/GLASSES/CL^4^129
 ;;^UTILITY(U,$J,358.4,1680,0)
 ;;=VISUAL FIELDS^6^129
 ;;^UTILITY(U,$J,358.4,1681,0)
 ;;=PHOTOGRAPHY^5^129
 ;;^UTILITY(U,$J,358.4,1682,0)
 ;;=LOW VISION^10^129
 ;;^UTILITY(U,$J,358.4,1683,0)
 ;;=SPECIAL PROCEDURES^7^129
 ;;^UTILITY(U,$J,358.4,1684,0)
 ;;=TEAM MEETINGS/CASE MANAGEMENT^9^129
 ;;^UTILITY(U,$J,358.4,1685,0)
 ;;=DILATED EXAM DIABETIC^1^129
 ;;^UTILITY(U,$J,358.4,1686,0)
 ;;=PROLONGED SVCS (W/ 99201-99215)^2^129
 ;;^UTILITY(U,$J,358.4,1687,0)
 ;;=EDUCATION/COUNSELING^8^129
 ;;^UTILITY(U,$J,358.4,1688,0)
 ;;=PROLONGED SVCS (W/O DIRECT PT CONTACT)^3^129
 ;;^UTILITY(U,$J,358.4,1689,0)
 ;;=INJECTION/ASPIRATION^3^130
 ;;^UTILITY(U,$J,358.4,1690,0)
 ;;=FRACTURE DISLOCATION^2^130
 ;;^UTILITY(U,$J,358.4,1691,0)
 ;;=APPLICATION CASTS/STRAPPING^1^130
 ;;^UTILITY(U,$J,358.4,1692,0)
 ;;=OTHER/REMOVAL/REVISION^4^130
 ;;^UTILITY(U,$J,358.4,1693,0)
 ;;=SUPPLIES/SOFT GOODS^8^130
 ;;^UTILITY(U,$J,358.4,1694,0)
 ;;=SUPPLIES/DRUGS^7^130
 ;;^UTILITY(U,$J,358.4,1695,0)
 ;;=REPAIR/CLOSURE-SIMPLE^6^130
 ;;^UTILITY(U,$J,358.4,1696,0)
 ;;=PROLONGED SERVICE^5^130
 ;;^UTILITY(U,$J,358.4,1697,0)
 ;;=NEW PATIENT^2^131
 ;;^UTILITY(U,$J,358.4,1698,0)
 ;;=ESTABLISHED PATIENT^1^131
 ;;^UTILITY(U,$J,358.4,1699,0)
 ;;=CONSULTATIONS^3^131
 ;;^UTILITY(U,$J,358.4,1700,0)
 ;;=POST OP^4^131
 ;;^UTILITY(U,$J,358.4,1701,0)
 ;;=ANKLE^3^132
 ;;^UTILITY(U,$J,358.4,1702,0)
 ;;=ELBOW^4^132
 ;;^UTILITY(U,$J,358.4,1703,0)
 ;;=FEMUR/THIGH^5^132
 ;;^UTILITY(U,$J,358.4,1704,0)
 ;;=FOOT/TOE^6^132
 ;;^UTILITY(U,$J,358.4,1705,0)
 ;;=FOREARM^7^132
 ;;^UTILITY(U,$J,358.4,1706,0)
 ;;=HAND/FINGER^8^132
 ;;^UTILITY(U,$J,358.4,1707,0)
 ;;=HUMERUS^9^132
 ;;^UTILITY(U,$J,358.4,1708,0)
 ;;=KNEE^10^132
 ;;^UTILITY(U,$J,358.4,1709,0)
 ;;=OTHER ^12^132
 ;;^UTILITY(U,$J,358.4,1710,0)
 ;;=PAIN^13^132
 ;;^UTILITY(U,$J,358.4,1711,0)
 ;;=PELVIS/HIP^14^132
 ;;^UTILITY(U,$J,358.4,1712,0)
 ;;=SHOULDER^17^132
 ;;^UTILITY(U,$J,358.4,1713,0)
 ;;=TIBIA/FIBULA^20^132
 ;;^UTILITY(U,$J,358.4,1714,0)
 ;;=WRIST^21^132
 ;;^UTILITY(U,$J,358.4,1715,0)
 ;;=AMPUTATION STATUS^2^132
 ;;^UTILITY(U,$J,358.4,1716,0)
 ;;=SECONDARY DX ONLY^15^132
 ;;^UTILITY(U,$J,358.4,1717,0)
 ;;=AFTERCARE/POST-OP/JOINT/SUTURE/DRESSING^1^132
 ;;^UTILITY(U,$J,358.4,1718,0)
 ;;=SPINE^18^132
 ;;^UTILITY(U,$J,358.4,1719,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^19^132
 ;;^UTILITY(U,$J,358.4,1720,0)
 ;;=PEER SERVICES^1^133
 ;;^UTILITY(U,$J,358.4,1721,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^134
 ;;^UTILITY(U,$J,358.4,1722,0)
 ;;=ANXIETY DISORDERS^2^134
 ;;^UTILITY(U,$J,358.4,1723,0)
 ;;=BIPOLAR & RELATED DISORDERS^3^134
 ;;^UTILITY(U,$J,358.4,1724,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^134
 ;;^UTILITY(U,$J,358.4,1725,0)
 ;;=DEPRESSIVE DISORDERS^7^134
 ;;^UTILITY(U,$J,358.4,1726,0)
 ;;=DISSOCIATIVE DISORDERS ^9^134
 ;;^UTILITY(U,$J,358.4,1727,0)
 ;;=FEEDING & EATING DISORDERS^12^134
 ;;^UTILITY(U,$J,358.4,1728,0)
 ;;=EDUC/OCCUPATIONAL PROBLEMS^10^134
 ;;^UTILITY(U,$J,358.4,1729,0)
 ;;=GENDER DYSPHORIA^14^134
 ;;^UTILITY(U,$J,358.4,1730,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^134
 ;;^UTILITY(U,$J,358.4,1731,0)
 ;;=MEDICATION ADVERSE EFFECTS^16^134
 ;;^UTILITY(U,$J,358.4,1732,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^134
